Latanoprost/Timolol Olikla

Timolol Maleate, the active ingredient in Latanoprost/Timolol Olikla, is a beta‑blocker and prostaglandin analog combination presented as an ophthalmic solution for ocular (topical) use. It treats open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost/Timolol Olikla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol Olikla is used to manage intraocular pressure in glaucoma and ocular hypertension.

- Open‑angle glaucoma: reduces intraocular pressure to slow disease progression. - Ocular hypertension: lowers elevated eye pressure to prevent development of glaucoma. - Secondary open‑angle glaucoma: helps control pressure when other treatments are insufficient.

Latanoprost/Timolol Olikla may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation: transient burning or stinging after instillation. - Conjunctival hyperemia: mild redness of the eye. - Eyelash changes: increased length or thickness. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Persistent ocular inflammation: uveitis or keratitis. - Systemic bradycardia: markedly reduced heart rate.

When using Latanoprost/Timolol Olikla, consider the following precautions.

- Contraindicated in patients with known hypersensitivity to beta‑blockers or prostaglandin analogues: avoid use. - Caution in patients with asthma, chronic obstructive pulmonary disease, or severe cardiac disease: monitor respiratory and cardiac status. - Use with care in patients with narrow-angle glaucoma: may precipitate angle closure. - Avoid concurrent use with other ocular beta‑blocker or prostaglandin products: risk of additive effects. - Discontinue if severe ocular irritation or allergic reaction occurs: seek medical advice. - Store at room temperature (below 25 °C): keep in original container, protect from light and moisture.

Latanoprost/Timolol Olikla can interact with several systemic and ocular agents.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers (e.g., propranolol): additive bradycardia or hypotension. - MAO inhibitors or other drugs affecting adrenergic tone: risk of severe cardiovascular effects. - Other prostaglandin analogues (e.g., bimatoprost): increased risk of ocular side effects.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce ocular surface lubrication, increasing irritation. - Carbonic anhydrase inhibitors (e.g., dorzolamide): potential additive intraocular pressure lowering. - Sympathomimetic eye drops (e.g., phenylephrine): may counteract beta‑blocker effect.